A class of extracellular vesicles from breast cancer cells activates VEGF receptors and tumour angiogenesis
Extracellular vesicles (EVs) contain VEGF and can contribute to tumour angiogenesis, although the mechanism remains unclear. Here, the authors find that a form of VEGF (VEGF90K) resistant to Bevacizumab but sensitive to HSP90 inhibitors, associates with EVs through its interaction with Hsp90.
Enregistré dans:
Auteurs principaux: | , , , , , , , , |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Nature Portfolio
2017
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/e17371e6af1d4dfba0a044b7db0d7907 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|